ALX Oncology Holdings Inc. | ||||
NMS : ALXO || Location: United States | ||||
$15.5+1.27 (+8.92%) |
0.44 M | 14.12 - 15.76 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 28, 2024 | 3.121 M |
March 15, 2024 | 2.914 M |
Feb. 29, 2024 | 3.478 M |
Feb. 15, 2024 | 3.531 M |
Jan. 31, 2024 | 3.620 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.86 | -0.93 | -8.35% |
09/30/2023 | -0.89 | -1.24 | -39.73% |
06/30/2023 | -0.90 | -0.84 | 6.42% |
03/31/2023 | -0.82 | -0.74 | 9.52% |
12/31/2022 | -0.90 | -0.75 | 17.03% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 50.152M | Shares Float | 22.300M |
Short Float | 3.121M | Market Cap | 777.36M |
Institution ownership | 97.60% | Insider ownership | 2.668% |
Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
Trailing EPS | -3.74 | Forward EPS | -2.96 |